Minimally Invasive Glaucoma Surgery Migs Devices Market Size, Share, Industry Trends and Forecast to 2030

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size & CAGR in 2021

The global minimally invasive glaucoma surgery (MIGS) devices market is projected to reach a market size of USD 1.5 billion in 2021, with a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period. The increasing prevalence of glaucoma and the growing demand for minimally invasive surgical procedures are driving the market growth.

COVID-19 Impact on the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

The COVID-19 pandemic has had a significant impact on the minimally invasive glaucoma surgery (MIGS) devices market. The lockdowns and restrictions imposed to curb the spread of the virus led to delays in elective surgeries, including glaucoma procedures. However, the market has shown resilience, with a gradual recovery as healthcare services resume. The focus on infection control measures and the shift towards outpatient procedures have influenced the market dynamics.

Minimally Invasive Glaucoma Surgery (MIGS) Devices Dynamics

The minimally invasive glaucoma surgery (MIGS) devices market is witnessing significant growth due to advancements in surgical techniques, increasing awareness about glaucoma, and the preference for minimally invasive procedures among patients. The market is also driven by technological innovations, such as microinvasive stents and implants, which offer improved outcomes and reduced risks compared to traditional surgical methods. As the aging population increases and the incidence of glaucoma rises, the demand for MIGS devices is expected to grow steadily.

Segments and Related Analysis

The minimally invasive glaucoma surgery (MIGS) devices market is segmented based on the type of devices, including microinvasive stents, minimally invasive implants, and drainage devices. Each segment offers unique benefits and caters to specific patient needs. The market analysis includes a detailed examination of market trends, growth drivers, challenges, and opportunities within each segment to provide valuable insights for stakeholders.

By Region Analysis

The minimally invasive glaucoma surgery (MIGS) devices market is analyzed regionally to assess market trends, regulatory landscape, and competitive dynamics in key regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Each region presents unique opportunities and challenges for market players, influencing their strategic decisions and market expansion strategies.

Key Market Players and Competitive Landscape

Leading players in the minimally invasive glaucoma surgery (MIGS) devices market include prominent companies such as Glaukos Corporation, Ivantis Inc., Santen Pharmaceutical Co., Ltd., Allergan (AbbVie Inc.), and Alcon (Novartis AG). These key market players are actively involved in product development, strategic collaborations, mergers and acquisitions, and geographical expansion to strengthen their market presence and gain a competitive edge. The competitive landscape of the market is dynamic, with new entrants and established players vying for market share through innovative solutions and advanced technologies.

Recent Happenings in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

The minimally invasive glaucoma surgery (MIGS) devices market has witnessed several recent developments, including product launches, regulatory approvals, and strategic collaborations. In 2020, Glaukos Corporation introduced a novel MIGS device for the treatment of glaucoma, expanding its product portfolio and market reach. Furthermore, Ivantis Inc. partnered with leading healthcare providers to enhance patient access to minimally invasive glaucoma surgical procedures. These developments demonstrate the ongoing innovation and growth opportunities in the MIGS devices market, positioning it for continued expansion and evolution in the years to come.